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The main machinery responsible for cellular protein maintenance is the ubiquitin-proteasomal system,
with its core particle the 20S proteasome. The main task of the system is a fast and efﬁcient degradation
of proteins not needed anymore in cellular metabolism. For this aim a complex system of regulators
evolved, modifying the function of the 20S core proteasome. Here we summarize shortly the structure
of the 20S proteasome as well as its associated regulator proteins.
& 2013 The Authors. Published by Elsevier B.V. Open access under CC BY-NC-ND license.ContentsIntroduction. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 178
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 181Introduction
The 20S proteasome is a multisubunit protease that can be
found even in the oldest bacteria (archaea) as well as in ‘‘modern’’
plants and animals. Evolutionary the proteasome gained new
functions supported by the development of several inducible
subunits and regulatory proteins. Those regulatory protein com-
plexes are able to bind to the 20S proteasome, changing its
substrate speciﬁcity and activity. In mammalian cells this com-
plex system contains the 20S proteasome, several regulators and
inhibitors and is involved in almost every cellular function as well
as in maintenance of cellular functionality.
The 20S proteasome is a cylindrical structure, built of four
rings, containing seven subunits each. The rings are arranged in
the sequence a-b-b-a, while the a-rings contain only a-, the
b-rings only b-subunits, accumulating a mass of about 700 kDa
(Fig. 1). In the archaeal form, the a-rings contain only one type ofer B.V.
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ne).
Open access under CC BY-NC-Na-subunits, as well as the b-rings contain only one type of
b-subunits. Substrate access to the inner proteolytic chamber is
regulated by the a-rings, while the proteolytic activity is localized
on the b-subunits, pointing to the inside of the proteolytic
chamber that is formed between the b-rings (Fig. 2). In order to
change substrate speciﬁcity, the archaeal 20S proteasome can
bind to PAN (proteasome-activating nucleotidase) [1,2], a regu-
lator protein, that enables the 20S proteasome to degrade natively
folded proteins in an ATP-dependent way (Fig. 3).
In contrast to the archaeal form, the ‘‘modern’’ eukaryotic form
of the 20S proteasome contains both seven different a-(a1–a7)
and b-subunits (b1–b7) (Fig. 1). Proteolytic activity is localized
only on three (instead of all) b-subunits (b1, b2, and b5). Further-
more, in mammals, a different set of active b-subunits can be
used in de novo synthesized proteasomes to form the so-called
inducible proteasome, playing a major role in MHCI-mediated
presentation of antigens during immune response. The expression
of the inducible fo5rms can be triggered by TNF-a, IFN-g or
lipopolysaccharides [3,4]. Together with the inducible form of the
20S proteasome, the 11S regulator protein is expressed, forming
the ‘‘immunoproteasome’’ via binding to the inducible form of
20S (i20S). The immunoproteasome shows increased activity
and produces short oligopeptides (8–10 amino acids) withD license.






















































Fig. 1. Structure of the archaeal and ‘‘modern’’ proteasome.
The proteasome (both the archaeal and the ‘‘evolutionary advanced’’ form) is a cylindrical structure formed of four rings, containing seven subunits, each. The rings are
arranged in the sequence a-b-b-a.
The upper row of this ﬁgure shows the structure of the archaeal 20S proteasome, the row below the structure of the eukaryotic form. In both cases, the most left images
show a simpliﬁed ball-model, different subunits are color coded. The archaeal proteasome contains only one type of alpha-subunits (pink) and only one type of beta-
subunits (green). The ‘‘modern’’ proteasome contains 7 different alpha- and beta-subunits (left image of the bottom row). Thus, the whole complex adds up an overall mass
of about 700 kDa and 28 subunits (both in the ancient and the ‘‘modern’’ form). In the case of the archaeal proteasome, there are only two (a and b), in the case of the
‘‘modern’’ proteasome, there are 14 (a1–a7 and b1–b7) different subunits.
In both rows the second image shows a high-detailed structure computed from data of X-ray-diffraction. For a better visualization, the different subunits of the archaeal
proteasome are color-coded, too (pink-shades for alpha- and green-shades for beta-subunits). The different subunits of the ‘‘modern’’ proteasome have the same color as in
the simple ball-model. The third image in both rows shows the inner structure after removing of several subunits from every single ring, exposing the inner structure. The
last image in both rows shows the same as the third one, but in grayscale for a better visibility of the inner structure.
The proteolytic activity is located on the beta-subunits; thus, the archaeal proteasome has an overall of 14 proteolytic centers, the eukaryotic proteasome has only two sets
of three (b1, b2, and b5). The alpha rings regulate substrate access to the proteolytic centers facing the inside of the proteasome (see Fig. 2 for more detailed information)
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Fig. 2. Structure of the eukaryotic proteasome.
In this image the single subunits are color coded (same colors as in Fig. 1). The whole proteasome is about 16 nm in height and has a diameter of about 10 nm [13].
The inside of the proteasome is subdivided into three chambers: two antechambers (with a volume of about 59 nm3, each) formed between an alpha- and a beta-ring, as
well as the main proteolytic chamber (volume of about 84 nm3) between the two beta-rings [14,15]. The centers of the proteolytic active subunits face the inside of the
main chamber, while substrate access is regulated by the alpha-rings, mediated by the N-terminal ends (last nine amino acids) of its single subunits. The exact function of
the antechambers is still unclear. In the eukaryotic proteasome, proteolytic activity is localized at the subunits b1, b2, and b5, thus 6 different proteolytic sides are available.
b1 has a peptidyl-glutamyl-peptide-hydrolyzing-activity (caspase-like, cleaving after acidic amino acids, also termed as ‘‘post-glutamyl-peptide hydrolytic’’-activity),
b2 provides a trypsin-like activity (cleaves after basic amino acids) and b5 a chymotrypsin-like activity (cleavage after neutral amino acids) [16]. The individual proteolytic
activity is b5bb24b1. Mouse mutants with both b5 and b2 knocked out are lethal, while b5/b1- and b1/b2-knockout-combinations are viable.
In the normal (non-activated) state, the proteasomal activity is very low. The N-terminal ends of the alpha-subunits block (gate) the channel (annulus) leading to the
proteolytic main chamber. In this state, substrate access is not possible. The main subunits involved in gating of the proteasome are a2, a3, and a4, while the gate is formed
by the last 10 amino acids of their N-terminal ends. Those N-terminal ends show a common motif, the so-called YDR-motif (Tyr8-Asp9-Arg10) that may act as a ‘‘joint’’,
bending away the blocking N-termini from the annulus [17]. a3DN-mutants in yeast, missing the last 9 amino acids reveal a constantly high proteolytic activity, while the
activity of a7DN-mutants is not signiﬁcantly increased [18]. The key element is the a3-subunit, virtually blocking the gate with its N-terminus like a bar.
As mentioned, the alpha-rings recognize proteasomal substrates or hydrophobic patches in substrates of unfolded proteins. The exact mechanism of substrate-recognition is still
unclear. It may be possible that the exposed hydrophobic sequences of soluble proteins bind to the alpha-rings and induce a conformational change, opening the gate to the main
chamber. A similar mechanism of recognition (exposed hydrophobic sequences) is found in the heat shock proteins Hsp70 and Hsp90 [19]. The gate of the 20S proteasome in the
‘‘non-activated’’ state has a diameter of about 0.9, after activation the annulus is extended to about 1.3–2.0 nm, sufﬁcient for the entrance of a protein chain. The products of
proteolytic degradation of unfolded proteins show different lengths in a range from 2–35 amino acids with three maxima: 2–3, 8–10, and 20–30 amino acids [20].
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Fig. 3. Regulator proteins of the archaeal and ‘‘modern’’ proteasome.
This ﬁgure shows the diversity of complexes of the archaeal (left part of the ﬁgure) and eukaryotic (right part of the ﬁgure) 20S proteasome with different regulator proteins. PAN:
the archaeal 20S proteasome (left side of the image) can only bind to a single type of regulator protein, the so-called PAN, an AAA-ATPase [21]. PAN is built of six identical
nucleotidases, forming a dome-shaped structure of about 650 kDa that binds to one or both alpha-rings. PAN enables the ATP-consuming degradation of natively folded proteins,
while the ‘‘uncapped’’ 20S can only degrade already unfolded substrates in an ATP-independent way. A special labeling of the substrate proteins with ubiquitin is not necessary. The
energy, provided by ATP, is needed only for unfolding the substrate that takes place at the surface of PAN, for gate-opening of 20S and for substrate translocation. For this, a
consumption of about 300–400 ATP-molecules was estimated by Benaroudj et al. [22] per processing of a whole native protein (in this case Benaroudj et al. used a GFP with a
C-terminal extension, summarizing about 250 amino acids). The degradation of the substrate itself by 20S is actually ATP-independent. Just the binding of ATP to PAN turned out to
be sufﬁcient for formation of the PAN–20S-complex, opening of the annulus, translocation and proteolytic degradation of unfolded substrate proteins; in contrast, unfolding and
degradation of native proteins by the PAN–20S-complex were dependent from ATP-hydrolysis.
The eukaryotic form of 20S can bind to different regulator caps (right part of this ﬁgure). Sometimes 20S binds to different regulators at the same time. 11S regulator: the so-called
immunoproteasome can be induced by IFN-g, TNF-a, or lipopolysaccharides [23]. In this case instead of the constitutive proteolytic subunits (b1, b2, and b5) of the constitutive 20S
proteasome (c20S) the inducible forms (ib1, ib2, and ib5) are used for during proteasomal synthesis. Due to a higher afﬁnity of ib5 compared to the constitutive b5 to Ump1 – this
complex is the initiator of 20S proteasome-assembly – in the presence of ib5 the formation of immunoproteasomes has a higher probability. Though, inducible and constitutive
subunits are coexpressed, resulting in formation of proteasomes that contain between a single one and the maximum of six of the inducible subunits, while the other subunits are
the constitutive ones. The inducible form of the proteasome shows a signiﬁcant shorter half-life of about 27 h compared to the constitutive form (8–12d) [24]. Thus, the cell is able to
respond quickly to pathogens or inﬂammatory processes and the inducible proteasome is also removed quickly, too. During aging, the amount of immunoproteasomes increases,
especially in postmitotic aging cells as in skeletal muscles, neurons, and astrocytes. Together with the inducible proteasomal subunits, the 11S regulator protein (also termed as
‘‘PA28’’ or ‘‘REG’’) is induced. Until now, three different 11S subunits are known: PA28a, PA28b, and PA28g. Both PA28a and PA28a are mainly found in the cytosol, mainly in
immune tissues. PA28g is found in the nuclei of cells. These subunits are able to form different hexa- and heptamers. In cells PA28a3b3, PA28a4b3 and PA28a3b4 (the subunits are
arranged in an alternating way) occur. PA28g (not inducible by IFN-g) forms PA28g7-homohepamers. The 11S-complex is 9 nm high, showing a diameter of about 6 nm; its central
channel has a diameter of 2–3 nm and induces proteasomal activity signiﬁcantly: b2-activity is increased 10-fold, both b1 and b5 50-fold, each [25,26]. PA28g increases only the
proteolytic activity of b2, while the other two activities are inhibited (to about 50%). The main task of the immunoproteasome is the production of short oligopeptides with
hydrophobic C-termini, that can be presented byMHC-I-molecules (immunohistocompatibility complex-I) on the surface of the cell. After recognition of unknown antigens by CD8þ
T-cells, the presenting cell is destroyed. As the constitutive proteasome, the immunoproteasome is only able to degrade (already unfolded) substrates in an ATP-independent way.
19S regulator: the 26S proteasome is technically a 20S ‘‘core’’ proteasome that binds a single 19S subunit (19S–20S), in contrast to the 30S proteasome (19S-20S-19S). Though, both
conformations are referred to as ‘‘26S’’ in the literature. 19S is the homolog of the archaeal PAN regulator protein (see above). The 19S regulator contains at least 19 different (known)
subunits: 6 subunits show an ATPase activity (Rpt1-Rpt6), the others do not (Rpn1–12 and Rpn15). The Rpt-subunits form a hexameric ring, that binds the alpha-ring of the
proteasome, the Rpn-subunits form a lid-like structure, that enables recognition and binding (Rpn10 and -13) of substrates. Binding of 19S activates the 20S ‘‘core’’ proteasome (Rpt2,
-3, and -5 are involved) and is dependent of the presence of both ATP andMg2þ . The whole 19S-complex has a mass of about 700 kDa. The 26S proteasome is the only conformation
of the eukaryotic proteasomal form that is able to degrade natively folded and fully functional substrate proteins in an ATP-consuming way. Labeling of those substrates is mediated
by polyubiquitination: a very complex system, involving four different types of E-enzymes (E1-E4), recognizes substrates and attaches a chain of ubiquitin (Ub) molecules that
provide the degradation signal to be recognized by the 19S regulator. Hybrid proteasomes (19S-20S-11S): binding of both an 11S and 19S regulator cap forms the ‘‘mixed’’-type (or
‘‘hybrid’’) proteasome, that can both degrade ATP-dependent and -independent. Its exact function is still not clear, it may be possible that it processes oligopeptides both ATP-
dependent and -independent, contributing to a widespread pool of oligopeptides for MHC-I presentation. Blm10/PA200: the third regulator of the proteasome is Blm10 (in yeast); the
mammalian homolog is termed as ‘‘PA200’’ (for protein activator 200 kDa). PA200 is only found in the nucleus of mammalian cells and its exact function is still unclear, though it
turned out to be involved in spermatogenesis [27] and DNA-repair [28]. Three different isoforms are known: PA200i, ii, and iii, while only PA200i really seems to bind the
proteasome. In contrast to other regulators it is a monomer, a dome-like shaped protein 10 nm in diameter and about 6 nm high with a weight of about 200 kDa. Blm10 binds to the
alpha-ring of the proteasome interacting with all alpha-subunits (while the mammalian PA200 does not interact with a7). After binding, gate-opening is induced and the
degradation of small protein fragments is increased. Besides its role as a proteasomal regulator, Blm10 is induced after DNA-damage by ionizing radiation and accumulates as
Blm10–20S complex on chromatin [29]. A further complex inducible by ionizing radiation, too, is 19S-20S-Blm10, that accumulates 24 h after exposure and shows a 19-fold
increased b1-activity and a 6-fold of b2. The 20S concentration at the chromatin increases 8-fold.
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Fig. 4. Relative amounts of free and regulator-bound 20S (in HeLa-cells).
In this ﬁgure one can see the relative amounts of free and regulator-bound proteasomes according to Tanahahsi et al. [30]. It turned out that proteasomes with only a single
regulator cap attached are very short-lived intermediates, undetectable via immunochemical methods. Thus, in the shown image actually two regulator caps are attached
and the 26S proteasome (right image) represents the 19S-20S-19S-conﬁguration (the 30S proteasome, to be exactly), not the 19S-20S-form. The immunoproteasome
(second image from the left) is also ﬁt out with two 11S-regulators.
T. Jung, T. Grune / Redox Biology 1 (2013) 178–182 181hydrophobic C-termini, ideal for MHC-I-presentation on the cells
surface to CD8þ-cells (cytotoxic T-lymphocytes).
While the 20S ‘‘core’’ proteasome (Fig. 2) is only able to
recognize and to degrade damaged/misfolded proteins that are
already unfolded, the 26S proteasome, main protease of the
ubiquitin–proteasome-system (UPS) is able to degrade natively
folded and functional proteins in an ATP- and ubiquitin-
dependent way. The 26S proteasome is formed by a 20S ‘‘core’’
proteasome, that binds one or two so-called 19S regulators (also
termed as PA700) [5,6] (Figs. 3 and 4). Binding to this regulator
increases proteasomal activity and enables the proteasome to
degrade substrate proteins that have been labeled by a complex
enzymatic machinery via the attachment of a chain of ubiquitin
(Ub) molecules [7].
Labeling of natively folded proteins by ubiquitin is realized by
four types of enzymes that work in a consecutive way [8]: the ﬁrst
step is the ATP-dependent ubiquitin-activation by E1 (‘‘ubiquitin-
activating enzyme’’), followed by transfer of Ub to E2 (‘‘ubiquitin-
conjugating enzyme’’). Some eight different E1- and a few dozen
of E2-enzymes are known today. Substrate speciﬁcity is delivered
by the E3-enzymes (about 650 known today): E3-Enzymes are
speciﬁc for a single or just a very few target proteins that are
bound to enable Ub-transfer from E2 to the substrate. Two
different types of E3-mediated Ub-transfer are known: RING
(direct Ub-transfer from E2 to the substrate) and HECT (Ub-
transfer from E2 to E3 and from E3 to the substrate). About 600
E3-enzymes count among the RING-form, the rest to the HECT
forms. After transfer of the ﬁrst Ub to the substrate, the Ub-chain
is quickly prolonged (a Ub4-chain provides the maximal signal for
26S-mediated proteolysis). The existence of E4-enzymes, respon-
sible for the prolongation of ubiquitin chains, is still under
discussion. It was claimed that E4 enzymes are a new class of
enzymes, whereas others state that E4 enzymes are just a
subclass of E3. Degradation of polyubiquitinated substrates fol-
lows the binding of the tagged substrate to the 19S-regulator, that
unfolds the target protein (needing ATP), and threads the protein
chain into the 20S ‘‘core’’ protein. The polyubiquitin chain is
degraded into its monomers by deubiqinating proteins (DUBs) to be
re-used by the E1-enzymes again. In addition to that the DUBs
provide a delicate balance between polyubiquitination (a common
posttranslational protein modiﬁcation) and deubiquitination, per-
manently adjusting the steady state of the cellular protein pool in a
very dynamic manner. Besides the degradation of not required
proteins the UPS is also responsible for the ‘‘quality control’’ of
protein folding and the endoplasmic-reticulum-associateddegradation (ERAD) [9], since 30–80% [10] of all newly synthesized
proteins are misfolded.
The proteasome has become a target in therapeutic treatment:
proteasomal inhibitors are used in certain cancer forms, including
multiple myeloma. Interestingly, similar strategies developed during
evolution: the HIV-I virus expresses a protein (HIV-I Vpu) that
targets C4D for ERAD-like degradation [11] and the human cyto-
megalovirus codes two proteins that transport MHC-I from the ER
into the cytosol followed by 26S-mediated degradation. Prions
(PrPSc) are actually able to inhibit the proteasome [12].References
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